Trading and Annuity Statement

Legal & General Group PLC 02 July 2004 Trading and annuity statement Legal & General Group Plc ('the Group') will hold a conference call for analysts and fund managers at 09.00 UK time today as it enters the closed period prior to the announcement of its interim financial results on 29 July 2004. In the second quarter of 2004, the Group has seen a marked increase in UK new business growth, which it believes indicates a return of consumer confidence in financial products. New business volumes in the second quarter of the year were more than 20% above both the first quarter of this year and the second quarter of last year, which is expected to be significantly above market expectations. Most product areas have shown growth but it was particularly strong in group protection business and unit-linked bonds with unit trusts showing a recovery from the first quarter. Sales of unit-linked bonds reflected a continuing switch by consumers away from with-profit bonds. The amount of bulk purchase annuity business written has improved but is below that in the first half of 2003. Term assurance volumes continue to be good and it is anticipated that Legal & General will remain the market leader in protection business. In its interim financial results announcement, the Group will also confirm the move to a more conservative mortality basis for reserving and reporting on its annuity business. Full details will be given in the interim results announcement on 29 July. However, preliminary guidance follows in this announcement. Commenting, David Prosser, Group Chief Executive, said 'Legal & General's new business growth has accelerated in the second quarter. We believe this reflects a return of consumer confidence in financial products reinforced by the continuing trend towards those companies which offer the combination of financial strength, operating efficiency and good value for money. These factors underline Legal & General's strong market position. 'In addition, the Group's Board has decided to move to a more conservative mortality basis for reporting on annuity business which will result in a net increase in reserves of less than £100m and a reduction in embedded value of less than 3p per share. Enquiries to: - Investors: Andrew Palmer, Group Director (Finance) 020 7528 6286 Peter Horsman, Head of Investor Relations 020 7528 6362 Media: John Morgan, Head of Public Relations 020 7528 6213 Anthony Carlisle, Citigate Dewe Rogerson 020 7638 9571 07973 611888 Conference Call There will be a conference call for analysts and fund managers at 09.00 UK time chaired by David Prosser, Group Chief Executive. Please access the conference call by dialling 0845 245 3471 from the UK or +44 (0)1452 542 300 from outside the UK. A brief slide presentation to introduce to the conference call may be found at http://investor.legalandgeneral.com/presentations.cfm A recording of this call will be available for one week at 0845 245 5205 from the UK or +44 (0)1452 550 000 from outside the UK (in the USA call 1866 247 4222). The access number is 1583476#. New mortality basis for annuity business Legal & General is a leading provider of annuity products. At 31 December 2003, reserves for this business amounted to £12.8bn of which Bulk Purchase Annuities represented 55%, Retained Money Annuities 25% and Compulsory Purchase Annuities 20%. The evidence from our more mature books of business is that mortality improvements have been in line with our recent Achieved Profits (AP) experience assumptions. However, recent research suggests that the current level of mortality improvement may persist for longer than previously anticipated and Legal & General has decided to adjust its mortality improvement bases accordingly. • The Board has decided to use the medium cohort table for improvements in male annuitant mortality experience in its AP reporting for its UK life and pensions business. For male annuitants, the average of medium cohort (MC) and long cohort (LC) will be used for reserving on the Modified Statutory Solvency (MSS) basis of reporting. The bases for female annuitant mortality will also be strengthened. • These changes in bases will reduce reported net embedded value as at 30 June 2004 by between £160m and £180m (less than 3p per share). This flows through to a reduction in pre tax AP operating profit of between £230m and £260m. We expect this reduction to be partially offset by positive experience variances and assumption changes as part of our half yearly review. • The annuity business written by the Group in 2004 is expected to deliver a double digit return on capital on both the old and new bases of reserving. Similarly, 2003 business on the new basis would also have shown a double digit return. • On the MSS basis at 30 June 2004, management estimates that there will be an overall net reduction of less than £100m in Shareholder Retained Capital, before taking account of any net capital strain which has been incurred in the normal course of our business in the first six months of the year. The new mortality basis will reduce Shareholder Retained Capital by between £270m and £310m net, equivalent to a fall in profit before tax of between £390m and £440m. However, this impact will be reduced by releases from other reserves during the first half of the year, together with the impact of improved asset/liability matching and other actions. • In the Board's view, there will be no material impact from these changes on the Group's dividend paying capacity. The following table indicates the changes in our experience and reserving assumptions: - Males Females AP experience MSS valuation AP experience MSS valuation Previous SC MC CMIR 17 CMIR 17 basis New basis MC 50% 70% of MC MC (MC+LC) The new MSS valuation basis for males has been set to establish broadly the same margin over AP experience assumptions as at the 2003 year end. Life expectancy based on both our end 2003 MSS reserving basis and our new reserving basis, is as follows: - Males aged 65 Old basis New basis @ 1/1/2004 MC 50% (MC+LC) (years) (years) BPA 20.5 21.3 RMA 20.7 21.5 CPA 23.0 23.9 Weighted Average 21.0 21.9 This information is provided by RNS The company news service from the London Stock Exchange
UK 100